Yanbin Zhou

1.8k total citations
50 papers, 1.3k citations indexed

About

Yanbin Zhou is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanbin Zhou has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanbin Zhou's work include Lung Cancer Treatments and Mutations (12 papers), Cancer-related gene regulation (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yanbin Zhou is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer-related gene regulation (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yanbin Zhou collaborates with scholars based in China, United States and Canada. Yanbin Zhou's co-authors include Lixia Huang, Shaoli Li, Jincui Gu, Ziying Lin, Xiaoxian Cui, Baomo Liu, Jennifer S. Carew, Peng Huang, Maher Albitar and Michael J. Keating and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Yanbin Zhou

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanbin Zhou China 22 646 389 264 248 171 50 1.3k
Huan Shi China 21 555 0.9× 462 1.2× 307 1.2× 378 1.5× 268 1.6× 55 1.5k
Liguo Liu China 21 554 0.9× 432 1.1× 185 0.7× 202 0.8× 266 1.6× 67 1.2k
Alessandro Gulino Italy 21 396 0.6× 288 0.7× 102 0.4× 151 0.6× 425 2.5× 53 1.3k
Chang Yang China 13 498 0.8× 250 0.6× 115 0.4× 339 1.4× 145 0.8× 37 953
Woo Kyun Bae South Korea 25 556 0.9× 599 1.5× 421 1.6× 167 0.7× 145 0.8× 136 1.7k
Xiaoli Hu China 20 697 1.1× 383 1.0× 201 0.8× 296 1.2× 136 0.8× 41 1.3k
E. Kay Ireland 18 496 0.8× 365 0.9× 158 0.6× 267 1.1× 149 0.9× 47 1.2k
Fangfang Shi China 21 838 1.3× 322 0.8× 97 0.4× 536 2.2× 158 0.9× 66 1.4k
Geneviève Paulissen Belgium 18 437 0.7× 273 0.7× 358 1.4× 214 0.9× 497 2.9× 27 1.5k
Hua‐Chien Chen Taiwan 25 957 1.5× 556 1.4× 118 0.4× 688 2.8× 130 0.8× 44 1.6k

Countries citing papers authored by Yanbin Zhou

Since Specialization
Citations

This map shows the geographic impact of Yanbin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbin Zhou more than expected).

Fields of papers citing papers by Yanbin Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanbin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbin Zhou. The network helps show where Yanbin Zhou may publish in the future.

Co-authorship network of co-authors of Yanbin Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yanbin Zhou. A scholar is included among the top collaborators of Yanbin Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanbin Zhou. Yanbin Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Yuanzheng, Qubo Zhu, Yanbin Zhou, Wenhu Zhou, & Yan Chen. (2025). Multifunctional nanomedicine targeting the 'seed-and-soil' of hair follicles via simultaneous alleviation of oxidative stress and activation of autophagy for androgenetic alopecia therapy. Materials Today Bio. 34. 102145–102145. 1 indexed citations
4.
Liang, Kun, et al.. (2024). Analysis of optimal planting scheme based on the North China region. Journal of Physics Conference Series. 2898(1). 12004–12004.
5.
Liu, Baomo, Yan Su, Shuaishuai Wang, et al.. (2024). The prognostic analysis and a machine-learning based disease-specific survival state model in pulmonary large-cell neuroendocrine carcinomas. Journal of Thoracic Disease. 16(8). 5152–5166. 1 indexed citations
6.
Deng, Haiyi, Xinqing Lin, Ziying Lin, et al.. (2023). A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case–Control Study. Clinical Drug Investigation. 43(5). 347–357. 7 indexed citations
7.
Li, Wenjie, Lixia Huang, Baomo Liu, et al.. (2023). Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey. Clinical & Translational Oncology. 26(3). 623–629. 2 indexed citations
8.
Liu, Peng, Ying Peng, Yanbin Zhou, et al.. (2021). Rapamycin as a “One-Stone-Three-Birds” Agent for Cooperatively Enhanced Phototherapies Against Metastatic Breast Cancer. ACS Applied Materials & Interfaces. 13(22). 25674–25684. 23 indexed citations
9.
Rong, Rong, Wei Chen, Zihao Dai, et al.. (2021). Improvement of the management of mental well-being and empathy in Chinese medical students: a randomized controlled study. BMC Medical Education. 21(1). 378–378. 14 indexed citations
10.
Gu, Jincui, Siqi Xu, Lixia Huang, et al.. (2018). Value of combining serum carcinoembryonic antigen and PET/CT in predicting EGFR mutation in non-small cell lung cancer. Journal of Thoracic Disease. 10(2). 723–731. 21 indexed citations
11.
Xie, Yang, Wei Lü, Shuai Wang, et al.. (2017). Validation of the 12-Gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer. Journal of Thoracic Oncology. 12(8). S1544–S1544. 4 indexed citations
12.
Gu, Jincui, Bing Liu, Lixia Huang, et al.. (2017). P2.03b-098 Comparison of Digital PCR, Ion Proton with ARMS-PCR in Tumor Tissue and Plasma of NSCLC Patients. Journal of Thoracic Oncology. 12(1). S996–S996. 1 indexed citations
13.
Fan, Fei, Seth Bellister, Jiahong Lu, et al.. (2014). The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells. British Journal of Cancer. 112(3). 539–546. 28 indexed citations
14.
Wang, Ying, Zhipeng Qu, Qiang Lü, et al.. (2014). Notch3 is important for TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1. Cancer Gene Therapy. 21(9). 364–372. 52 indexed citations
15.
Zhou, Yanbin, et al.. (2014). Diagnosis of lymph node micrometastasis at the pN0 stage of lung adenocarcinoma using a combination of markers. Genetics and Molecular Research. 13(3). 5594–5600. 3 indexed citations
16.
Wang, Qinqin, Yanbin Zhou, Shaoli Li, et al.. (2013). Real-Time Fluorescence Loop Mediated Isothermal Amplification for the Detection of Acinetobacter baumannii. PLoS ONE. 8(7). e66406–e66406. 32 indexed citations
17.
Li, Shaoli, Yanbin Zhou, Weijun Ou, et al.. (2013). Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression. Cytokine. 65(1). 24–32. 63 indexed citations
18.
Yang, Jiyong, Yusheng Chen, Xiaodong Jia, et al.. (2012). Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clinical Microbiology and Infection. 18(12). E506–E513. 76 indexed citations
19.
He, Yong, Zhen Zhou, Wayne L. Hofstetter, et al.. (2012). Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters. PLoS ONE. 7(2). e31087–e31087. 33 indexed citations
20.
Zhou, Yanbin, Wayne L. Hofstetter, Yong He, et al.. (2010). KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer Biology & Therapy. 9(7). 507–513. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026